Abstract
In the past 5 years there has been a significant shift in the focus of heart failure epidemiology research. In the 1960 to 1995 era, persons with overt clinical heart failure were identified by assessment of typical symptoms and signs of heart failure. Recent work has gone beyond symptoms and signs, to include objective echocardiographic measurement of ventricular function. This approach has revealed that most cases of ventricular dysfunction are asymptomatic. It has also underscored the high prevalence of diastolic ventricular dysfunction in the very elderly. Nevertheless, recent data suggest that advances in heart failure therapy may be resulting in improved survival for heart failure patients in the community. Future efforts need to be directed toward early detection of ventricular dysfunction and prevention of symptomatic heart failure.
Similar content being viewed by others
References and Recommended Reading
McKee PA, Castelli WP, McNamara PM, Kannel WB: The natural history of congestive heart failure: the Framingham Study. N Engl J Med 1971, 285:1441–1446.
Rodeheffer RJ, Jacobsen SJ, Gersh BJ, et al.: The incidence and prevalence of congestive heart failure in Rochester, Minnesota. Mayo Clin Proc 1993, 68:1143–1150.
Remes J, Reunanen A, Aromaa A, Pyorala K: Incidence of heart failure in eastern Finland: a population-based surveillance study. Eur Heart J 1992, 13:588–593.
Schocken DD, Arrieta MI, Leaverton PE, Ross EA: Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992, 20:301–306.
Congestive heart failure in the United States: a new epidemic. National Heart Lung and Blood Institute fact sheet. Bethesda: National Heart Lung and Blood Institute; 1996.
The SOLVD Investigators: Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992, 327:685–691.
Pfeffer MA, Braunwald E, Moye LA, et al.: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992, 327:669–677.
McDonagh TA, Morrison CE, Lawrence A, et al.: Symptomatic and asymptomatic left ventricular systolic dysfunction in an urban population. Lancet 1997, 350:829–833. The first study to describe the prevalence of systolic ventricular dysfunction.
Redfield MM, Jacobsen SJ, Burnett JC, Jr, et al.: Burden of systolic and diastolic ventricular dysfunction in the community. JAMA 2003, 289:194–202. The most comprehensive assessment of ventricular function in a population-based cohort; the first to assess both systolic and diastolic ventricular function and provide community data on the impact of diastolic dysfunction survival.
Vasan RS, Benjamin EJ, Levy D: Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995, 26:1565–1574.
Kitzman DW, Gardin JM, Gottdiener JS, et al.: Importance of heart failure with preserved systolic function in patients ≥ 65 years of age. Am J Cardiol 2001, 87:413–419.
Davies MK, Hobbs FDR, Davis RC, et al.: Prevalence of leftventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population-based study. Lancet 2001, 358:439–444.
Gottdiener JS, Arnold AM, Aurigemma GP, et al.: Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 2000, 35:1628–1637.
Levy D, Garrison RJ, Savage DD, et al.: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990, 322:1561–1566.
Gardin JM, McClelland R, Kitzman D, et al.: M-mode echocar-diographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in elderly cohort (The Cardiovascular Health Study). Am J Cardiol 2001, 87:1051–1057.
Vasan RS, Larson MG, Benjamin EJ, et al.: Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med 1997, 336:1350–1355. This paper provides important evidence supporting the long-held clinical assumption that systolic ventricular dysfunction is a progressive condition. Persons with enlarged LV chambers were at higher risk of developing subsequent overt heart failure.
Kenchaiah S, Evans JC, Levy D, et al.: Obesity and the risk of heart failure. N Engl J Med 2002, 347:305–313.
Ho KKL, Anderson KM, Kannel WB, et al.: Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation 1993, 88:107–115.
Senni M, Redfield MM: Congestive heart failure in elderly patients. Mayo Clin Proc 1997, 72:453–460.
Senni M, Tribouilloy CM, Rodeheffer RJ, et al.: Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998, 98:2282–2289. A useful population-based study underscoring the high incidence of CHF in the very elderly.
Senni M, Tribouilloy CM, Rodeheffer RJ, et al.: Congestive heart failure in the community: trends in incidence and survival in a 10-year period. Arch Intern Med 1999, 159:29–34.
Levy D, Kenchaiah S, Larson MG, et al.: Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002, 347:1397–1402. An important report providing the first evidence that survival in heart failure patients in the community is improving.
Massie BM, Conway M: Survival of patients with congestive heart failure: Past, present, and future prospects. Circulation 1987, 75(Suppl IV):IV–11-IV–19.
The CONSENSUS Trial Study Group: Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987, 316:1429–1435.
The SOLVD Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991, 325:293–302.
McDonagh TA, Robb SD, Murdoch DR, et al.: Biochemical detection of left ventricular systolic dysfunction. Lancet 1998, 351:9–13. An important report describing the negative predictive value of a normal plasma BNP level in excluding the presence of systolic LVD.
Vasan RS, Benjamin EJ, Larson MG, et al.: Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction. The Framingham Heart Study. JAMA 2002, 288:1252–1259. A cautionary study describing the suboptimal sensitivity and specificity of plasma BNP in community screening for systolic ventricular dysfunction.
Devereux RB, Roman MJ, Paranicas M, et al.: A populationbased assessment of left ventricular systolic dysfunction in middle-aged and older adults: the Strong Heart Study. Am Heart J 2001, 141:439–446.
Gardin JM, Siscovick D, Anton-Culver H, et al.: Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly. Circulation 1995, 91:1739–1748.
Bröckel U, Hense HW, Muscholl M, et al.: Prevalence of left ventricular dysfunction in the general population 901–66. J Am Coll Cardiol 1996, 27(Suppl 2):1.
Mosterd A, Hoes AW, de Bruyne MC, et al.: Prevalence of heart failure and left ventricular dysfunction in the general population: The Rotterdam study. Eur Heart J 1999, 20:447–455.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rodeheffer, R.J. The new epidemiology of heart failure. Curr Cardiol Rep 5, 181–186 (2003). https://doi.org/10.1007/s11886-003-0046-8
Issue Date:
DOI: https://doi.org/10.1007/s11886-003-0046-8